0000000001179718

AUTHOR

Miriam Buttacavoli

showing 21 related works from this author

A multiomics analysis of S100 protein family in breast cancer

2018

The S100 gene family is the largest subfamily of calcium binding proteins of EF-hand type, expressed in tissue and cell-specific manner, acting both as intracellular regulators and extracellular mediators. There is a growing interest in the S100 proteins and their relationships with different cancers because of their involvement in a variety of biological events closely related to tumorigenesis and cancer progression. However, the collective role and the possible coordination of this group of proteins, as well as the functional implications of their expression in breast cancer (BC) is still poorly known. We previously reported a large-scale proteomic investigation performed on BC patients f…

0301 basic medicinePathway analysiBiologyProteomicsmedicine.disease_causeBreast cancer; Expression analysis; Pathway analysis; Proteomics; S100 proteins; OncologyTranscriptome03 medical and health sciencesproteomics0302 clinical medicineBreast cancerBreast cancerExpression analysiSettore BIO/13 - Biologia ApplicataCalcium-binding proteinmedicineGene familyexpression analysisSettore BIO/06 - Anatomia Comparata E CitologiaCancerProteomicmedicine.diseasePhenotypepathway analysisS100 proteinSettore BIO/18 - Genetica030104 developmental biologyOncology030220 oncology & carcinogenesisCancer researchCarcinogenesisS100 proteinsResearch Paper
researchProduct

The effects of structural changes on the anti-microbial and anti-proliferative activities of diimidazolium salts

2017

An array of diimidazolium salts has been synthesized and used to investigate their anti-microbial and anti-proliferative activities. In particular, salts based on the 3,30-di-n-alkyl-1,10-(1,n-phenylenedimethylene)- diimidazolium cation and differing in the alkyl chain length on the imidazolium ion, the isomeric substitution on the aromatic spacer and in the anion nature were used. The anti-proliferative activity was evaluated against cervical (HeLa), colon adenocarcinoma (HT-29) and breast (SKBR3) cancer cell lines. In the latter case, also a morphological assessment after treatment with salts was performed. All salts were tested for their hemolytic activity against human erythrocytes. On …

StereochemistryBacillus subtilis010402 general chemistrymedicine.disease_causeSettore BIO/19 - Microbiologia Generale01 natural sciencesCatalysisHeLaMaterials ChemistrymedicineSettore BIO/06 - Anatomia Comparata E CitologiaEscherichia coliAlkylchemistry.chemical_classificationbiology010405 organic chemistryChemistryCationic polymerizationdiimidazolium salts anti-bacterial activity anti-proliferative activityBiological activityGeneral ChemistrySettore CHIM/06 - Chimica Organicabiology.organism_classificationAntimicrobial0104 chemical sciencesSettore BIO/18 - GeneticaSKBR3
researchProduct

Prognostic and functional significant of mmp2 and mmp9 in breast cancer unveiled by proteomic analysis

2022

matrix metalloproteinases breast cancer biomarkersSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Multi-omics analysis of epithelial-to mesenchymal transition mediators in breast cancer

2022

breast cancer bioinformatics proteomic analysis vimentin cadherinSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Proteomic Profiling of Colon Cancer Tissues: Discovery of New Candidate Biomarkers

2020

Colon cancer is an aggressive tumor form with a poor prognosis. This study reports a comparative proteomic analysis performed by using two-dimensional differential in-gel electrophoresis (2D-DIGE) between 26 pooled colon cancer surgical tissues and adjacent non-tumoral tissues, to identify potential target proteins correlated with carcinogenesis. The DAVID functional classification tool revealed that most of the differentially regulated proteins, acting both intracellularly and extracellularly, concur across multiple cancer steps. The identified protein classes include proteins involved in cell proliferation, apoptosis, metabolic pathways, oxidative stress, cell motility, Ras signal transdu…

AdultMaleProteomics0301 basic medicinetransgelinColorectal cancerpathway analysiproteomic profilingBiologymedicine.disease_causeArticleCatalysisInorganic Chemistrylcsh:Chemistry03 medical and health sciences0302 clinical medicineBiomarkers TumorTumor MicroenvironmentmedicineHumansElectrophoresis Gel Two-DimensionalProtein Interaction MapsPhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5SpectroscopyInnate immune systemTAGLProteomic ProfilingOrganic ChemistryCancerGeneral MedicineMiddle Agedmedicine.diseaseComputer Science Applicationspathway analysisGene Expression Regulation Neoplastic030104 developmental biologycolon cancerlcsh:Biology (General)lcsh:QD1-999030220 oncology & carcinogenesisColonic NeoplasmsNeutrophil degranulationCancer researchBiomarker (medicine)FemaleSignal transductionCarcinogenesisInternational Journal of Molecular Sciences
researchProduct

Prognostic and Functional Significant of Heat Shock Proteins (HSPs) in Breast Cancer Unveiled by Multi-Omics Approaches

2021

Simple Summary In this study, we investigated the expression pattern and prognostic significance of the heat shock proteins (HSPs) family members in breast cancer (BC) by using several bioinformatics tools and proteomics investigations. Our results demonstrated that, collectively, HSPs were deregulated in BC, acting as both oncogene and onco-suppressor genes. In particular, two different HSP-clusters were significantly associated with a poor or good prognosis. Interestingly, the HSPs deregulation impacted gene expression and miRNAs regulation that, in turn, affected important biological pathways involved in cell cycle, DNA replication, and receptors-mediated signaling. Finally, the proteomi…

endocrine systemHSPschemical and pharmacologic phenomenaBiologymedicine.disease_causeProteomicsArticleGeneral Biochemistry Genetics and Molecular Biologybreast cancerproteomicsHeat shock proteinexpressionmicroRNAmedicineHSPEpithelial–mesenchymal transitionlcsh:QH301-705.5GeneproteomicGeneral Immunology and MicrobiologyCancerhemic and immune systemsdata miningCell cyclemedicine.diseaselcsh:Biology (General)biological sciencesmiRNAsCancer researchprognosisGeneral Agricultural and Biological SciencesCarcinogenesisprognosiBiology
researchProduct

Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Agg…

2019

Breast cancer is a complex and heterogeneous disease: Several molecular alterations cause cell proliferation and the acquisition of an invasive phenotype. Extracellular matrix (ECM) is considered essential for sustaining tumor growth and matrix metalloproteinases (MMPs) have been identified as drivers of many aspects of the tumor phenotype. Mounting evidence indicates that both &alpha

0301 basic medicineAlpha-enolaseENO1Kaplan-Meier EstimateMatrix metalloproteinasemedicine.disease_causeMetastasisExtracellular matrixlcsh:Chemistry0302 clinical medicineSettore BIO/06 - Anatomia Comparata E Citologialcsh:QH301-705.5SpectroscopybiologyMMP-2General MedicineComputer Science ApplicationsDNA-Binding ProteinsGene Expression Regulation NeoplasticMatrix Metalloproteinase 9030220 oncology & carcinogenesisDisease ProgressionMatrix Metalloproteinase 2FemaleMMP-9Breast NeoplasmsCatalysisArticleInorganic Chemistry03 medical and health sciencesBreast cancerbreast cancerCell Line TumormedicineBiomarkers TumorHumansPhysical and Theoretical ChemistryMBP-1Molecular BiologyCell ProliferationTumor Suppressor ProteinsOrganic ChemistryCancermedicine.diseaseSettore BIO/18 - Genetica030104 developmental biologylcsh:Biology (General)lcsh:QD1-999Phosphopyruvate HydrataseCancer cellbiology.proteinCancer researchCarcinogenesisInternational Journal of Molecular Sciences
researchProduct

Anticancer activity of biogenerated silver nanoparticles: an integrated proteomic investigation

2018

Silver nanoparticles (AgNPs), embedded into a specific polysaccharide (EPS), were biogenerated by Klebsiella oxytoca DSM 29614 under aerobic (AgNPs-EPSaer) and anaerobic conditions (AgNPs-EPSanaer). Both AgNPs-EPS matrices were tested by MTT assay for cytotoxic activity against human breast (SKBR3 and 8701-BC) and colon (HT-29, HCT 116 and Caco-2) cancer cell lines, revealing AgNPs-EPSaer as the most active, in terms of IC50, with a more pronounced efficacy against breast cancer cell lines. Therefore, colony forming capability, morphological changes, generation of reactive oxygen species (ROS), induction of apoptosis and autophagy, inhibition of migratory and invasive capabilities and prote…

0301 basic medicineProgrammed cell deathSettore BIO/11 - Biologia MolecolareMitochondrionmedicine.disease_causeSettore BIO/19 - Microbiologia Generale03 medical and health sciencesproteomicsbreast cancer cellmedicineMTT assaySettore BIO/06 - Anatomia Comparata E Citologiabacteriachemistry.chemical_classificationAnticancer activity; Bacteria; Breast cancer cells; Proteomics; Silver nanoparticles (AgNPs); OncologyReactive oxygen speciesBreast cancer cellsChemistryAutophagysilver nanoparticles (AgNPs)Cell biology030104 developmental biologyanticancer activitysilver nanoparticles (AgNPs); bacteria; breast cancer cells; anticancer activity; proteomicsOncologyApoptosisSKBR3Oxidative stressResearch Paper
researchProduct

New Synthetic Nitro-Pyrrolomycins as Promising Antibacterial and Anticancer Agents

2020

: Pyrrolomycins (PMs) are polyhalogenated antibiotics known as powerful biologically active compounds, yet featuring high cytotoxicity. The present study reports the antibacterial and antitumoral properties of new chemically synthesized PMs, where the three positions of the pyrrolic nucleus were replaced by nitro groups, aiming to reduce their cytotoxicity while maintaining or even enhancing the biological activity. Indeed, the presence of the nitro substituent in diverse positions of the pyrrole determined an improvement of the minimal bactericidal concentration (MBC) against Gram-positive (i.e., Staphylococcus aureus) or -negative (i.e., Pseudomonas aeruginosa) pathogen strains as compare…

0301 basic medicineMicrobiology (medical)Staphylococcus aureusmedicine.drug_classAntibioticspyrrolomycinmedicine.disease_causeSettore BIO/19 - Microbiologia Generale01 natural sciencesBiochemistryMicrobiologypyrrolic nucleusHCT116Article03 medical and health sciencesantibacterial activityMCF 7medicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsSettore BIO/06 - Anatomia Comparata E CitologiaCytotoxicityheterocyclesMinimum bactericidal concentrationantitumoral activity010405 organic chemistryChemistryPseudomonas aeruginosalcsh:RM1-950MCF7Biological activitySettore CHIM/08 - Chimica Farmaceutica0104 chemical scienceslcsh:Therapeutics. Pharmacology030104 developmental biologyInfectious DiseasesMCF-7BiochemistryStaphylococcus aureusPseudomonas aeruginosaNitroAntibiotics
researchProduct

Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis

2023

Pyrrolomycins (PMs) are a family of naturally occurring antibiotic agents, isolated from the fermentation broth of Actinosporangium and Streptomyces species. Pursuing our studies on pyrrolomycins, we performed the total synthesis of the F-series pyrrolomycins (1–4) by microwave-assisted synthesis (MAOS), thus obtaining the title compounds in excellent yields (63–69%). Considering that there is no evidence so far of the anticancer effect of this class of compounds, we investigated PMs for their antiproliferative activity against HCT116 and MCF-7 cancer cell lines. PMs showed anticancer activity at submicromolar level with a minimal effect on normal epithelial cell line (hTERT RPE-1), and the…

PharmacologyOrganic ChemistryDrug DiscoveryPyrrolomycin Anticancer activity Microwave-assisted organic synthesis (MAOS) Vacuoles Tunneling nanotubes (TNTs) FilopodiaGeneral MedicineSettore BIO/06 - Anatomia Comparata E CitologiaSettore CHIM/08 - Chimica FarmaceuticaEuropean Journal of Medicinal Chemistry
researchProduct

In vitro effects of AGNPs exopolysaccharide from Klebsiella Oxytoca DSM29614 on breast cancer cells

2015

nanoparticles antineoplastic molecules breast cancer proteomicSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

New insights of epithelial-to-mesenchymal transition (EMT) signature in breast cancer

2023

Settore BIO/06 - Anatomia Comparata E Citologiaepithelial-to-mesenchymal transition breast cancer bioinformatics vimentin cadherinbio
researchProduct

Potentially useful diagnostic and prognostic markers in colon cancer: a proteomic-based investigation

2019

colonrectal cancer proteomic biomarkers transgelinSettore BIO/06 - Anatomia Comparata E Citologia
researchProduct

Zymographic Analysis of Matrix Metalloproteinases (MMP-2 and MMP-9) in Cerebrospinal Fluid and Sera from Patients with Multiple Sclerosis

2023

Settore BIO/06 - Anatomia Comparata E CitologiaZymographic Analysis Matrix Metalloproteinases Multiple Sclerosis Cerebrospinal Fluid extracellular vesicles
researchProduct

Integrated multi-omics investigations of metalloproteinases in colon cancer: Focus on MMP2 and MMP9

2021

Colorectal cancer (CRC) develops by genetic and epigenetic alterations. However, the molecular mechanisms underlying metastatic dissemination remain unclear and could benefit from multi-omics investigations of specific protein families. Matrix metalloproteinases (MMPs) are proteolytic enzymes involved in ECM remodeling and the processing of bioactive molecules. Increased MMP expression promotes the hallmarks of tumor progression, including angiogenesis, invasion, and metastasis, and is correlated with a shortened survival. Nevertheless, the collective role and the possible coordination of MMP members in CRC are poorly investigated. Here, we performed a multi-omics analysis of MMP expression…

ProteomicsMMP2Epithelial-Mesenchymal TransitionQH301-705.5Colorectal cancerBioinformaticsKaplan-Meier EstimateBiologyMatrix metalloproteinaseMMP9ArticleCatalysisEpigenesis GeneticMetastasisCohort StudiesInorganic ChemistryLymphocytes Tumor-InfiltratingmedicineHumansEpithelial–mesenchymal transitionBiology (General)Physical and Theoretical ChemistrySettore BIO/06 - Anatomia Comparata E CitologiaQD1-999Molecular BiologySpectroscopyTissue Inhibitor of Metalloproteinase-2Functional analysisMMP9Organic ChemistryProteolytic enzymesGeneral Medicinemedicine.diseasePrognosisComputer Science ApplicationsColon cancerExtracellular MatrixGene Expression Regulation NeoplasticChemistryMatrix metalloproteinasesMatrix Metalloproteinase 9Tumor progressionCase-Control StudiesColonic NeoplasmsCancer researchMatrix Metalloproteinase 2Gene expressionMMP2
researchProduct

Functional investigations of matrix metalloproteinases in breast cancer: focus on MMP9 and MMP2

2021

Settore BIO/06 - Anatomia Comparata E Citologiamatrix metalloproteinases biomarkers breast cancer
researchProduct

DICATIONIC IMIDAZOLIUM SALTS: TUNABLE ANTIMICROBIAL AND ANTITUMORAL CHEMIOTHERAPEUTIC LEADS

2015

The chemical synthesis of novel chemotherapeutical leads is evolving thanks to possibility to design molecules with desired physical-chemical and, thus, biological properties. The imidazolium salts, recently proven effective to inhibit bacterial and/or cancer cell growth, posses an amphiphilic nature that is conferred by the imidazolium cation having a polar head generally coupled with aliphatic side chains. Thus, biological properties of imidazolium salts can be tuned through modifications involving the cation structure and/or the anion nature. By covalently linking two imidazolium rings, di-imidazolium salts were obtainedobtain differing in: i) kind of anions; ii) geometric isomerization …

DICATIONIC IMIDAZOLIUM SALTS ANTITUMORAL ANTIMICROBIAL
researchProduct

Proteomica comparata di un frammento chirurgico di carcinoma del colon e della metastasi epatica associata

2013

carcinoma colon
researchProduct

PROTEOMIC IDENTIFICATION OF NOVEL MARKERS IN BREAST AND COLON CANCER

Background: Discovery of new biomarker represent the greatest promise for the detection and management of cancer. Although progress in cancer biology has been rapid during the past few years, the complete understanding of molecular basis for cancer initiation, progression and efficacious treatments is still lacking. In this context, the application of proteomic strategies is now holding a focal position. The main reason is that proteins are the functional players that drive cancer phenotypes. Among cancers, breast and colon represent the most frequent forms. The evolution of these type of cancer are not easily predictable since there are several types that behave differently among patients.…

ProteomicsBIOMARKERsilver nanoparticlesBreast cancercolon cancerPROTEOMICCOLON CANCERSettore BIO/06 - Anatomia Comparata E CitologiaBREAST
researchProduct

Comparative Proteomics of Surgical Fragments of Colorectal Cancer with Non-tumoral Mucosa and Associated Liver Metastasis

2013

Colon Cancer Proteomics
researchProduct

PROTEOMIC SIGNATURE OF HUMAN PRIMARY METASTATIC COLON CANCER AND ITS METASTASES TO LIVER

2014

colon cancer
researchProduct